Texas Biomed News
Four of the city's large research institutions announced Wednesday they have formed a partnership to develop new vaccines. All four already have vaccine research under way. The new partnership, called the San Antonio Vaccine Development Center, could have almost $1 million in new funds to spur scientists in new directions, said Kenneth Trevett, president of the Texas Biomedical Research Institute.
| Read the full story
Emergence of resistance to the drug artemisinin in western Thailand has created a critical point in global efforts to control and eliminate malaria worldwide, according to researchers at the Texas Biomedical Research Institute and their collaborators in Thailand. A second study by the same research groups, identifies a major region of the malaria parasite genome associated with artemisinin resistance, raising hope that there will soon be effective molecular markers for monitoring the spread of resistance.
| Read the full story
Two off-the-shelf cancer drugs blocked the deadly Ebola virus from reproducing in the test tube — an early, promising advance in a disease and potential biological weapon with no approved treatments or vaccine, scientists report.
| Read the full story